New research grants target ALS causes, biomarkers, gene therapy
The ALS Network, in collaboration with ALS United, has announced the winners…
Articles by Patricia Inácio, PhD
Deal aimed at developing therapy to fight toxic protein in ALS, FTD
Transition Bio and Voyager Therapeutics are teaming up to discover and develop new small molecules that target the…
Target ALS film follows founder’s mission to transform research
Target ALS has released a short documentary that follows the deeply personal journey of Dan Doctoroff, the organization’s founder…
‘Grey’s Anatomy’ actor named ALS Network’s advocate of the year
The ALS Network is honoring actor Eric Dane as its Advocate of the Year, granting the former TV doctor…
UCLA ALS Clinic becomes 100th Treatment Center of Excellence
The UCLA ALS Clinic and Research Center has been officially designated a Certified Treatment Center of Excellence for people…
Push for Progress campaign seeks to boost ALS treatment, research
Nonprofit I AM ALS has teamed up with actor Eric Dane to launch Push for Progress, a three-year…
Surf Away+ event brings fun in the sun to people with rare diseases
Ionis Pharmaceuticals recently celebrated the 10th anniversary of its Surf Away+ program, a day of adaptive sports and beach…
First Hoffman award winners to expand multidisciplinary ALS care
The ALS Association has announced the winners of its first-ever Hoffman ALS Clinic Development and Capacity Awards, two new grant…
Access to investigational ALS therapy MN‑166 expanded further
The ongoing program that is providing amyotrophic lateral sclerosis (ALS) patients with access to Medicinova’s investigational therapy MN‑166…
ALS gene therapy candidate KLTO‑202 wins orphan drug status
The U.S. Food and Drug Administration (FDA) has granted orphan drug status to Klotho Neurosciences’ gene therapy candidate for…